The components of basic and diluted earnings per share are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
(In thousands, except per share data) |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(10,903 |
) |
|
$ |
(13,782 |
) |
|
$ |
(25,960 |
) |
|
$ |
(31,297 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding, basic |
|
|
27,770 |
|
|
|
27,385 |
|
|
|
27,667 |
|
|
|
27,362 |
|
Dilutive effect of stock options (1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Dilutive effect of restricted stock units (1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Weighted average common shares outstanding, diluted |
|
|
27,770 |
|
|
|
27,385 |
|
|
|
27,667 |
|
|
|
27,362 |
|
Net loss per share, basic |
|
$ |
(0.39 |
) |
|
$ |
(0.50 |
) |
|
$ |
(0.94 |
) |
|
$ |
(1.14 |
) |
Net loss per share, diluted |
|
$ |
(0.39 |
) |
|
$ |
(0.50 |
) |
|
$ |
(0.94 |
) |
|
$ |
(1.14 |
) |
Anti-dilutive securities excluded from diluted loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Anti-dilutive stock options (1) |
|
|
780 |
|
|
|
927 |
|
|
|
797 |
|
|
|
950 |
|
Anti-dilutive restricted stock units (1) |
|
|
640 |
|
|
|
138 |
|
|
|
648 |
|
|
|
134 |
|
Anti-dilutive warrants |
|
|
1,452 |
|
|
|
1,452 |
|
|
|
1,452 |
|
|
|
1,452 |
|
Anti-dilutive performance-based restricted stock units |
|
|
— |
|
|
|
119 |
|
|
|
36 |
|
|
|
119 |
|
(1) Due to the net loss during each of the three and six months ended June 30, 2025 and 2024, no dilutive securities were included in the calculation of diluted loss per share because they would have been anti-dilutive.
|